These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 29649743)
41. Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones. Ducki S; Mackenzie G; Greedy B; Armitage S; Chabert JF; Bennett E; Nettles J; Snyder JP; Lawrence NJ Bioorg Med Chem; 2009 Nov; 17(22):7711-22. PubMed ID: 19837594 [TBL] [Abstract][Full Text] [Related]
42. Towards modern anticancer agents that interact with tubulin. La Regina G; Coluccia A; Naccarato V; Silvestri R Eur J Pharm Sci; 2019 Apr; 131():58-68. PubMed ID: 30690185 [TBL] [Abstract][Full Text] [Related]
43. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker. Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940 [TBL] [Abstract][Full Text] [Related]
44. Conformation impacts on the bioactivities of SMART analogues. Wu Y; Guan Q; Zheng D; Yan P; Feng D; Du J; Zhang J; Zuo D; Bao K; Zhang W Eur J Med Chem; 2018 Oct; 158():733-742. PubMed ID: 30245397 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site. Li W; Shuai W; Sun H; Xu F; Bi Y; Xu J; Ma C; Yao H; Zhu Z; Xu S Eur J Med Chem; 2019 Feb; 163():428-442. PubMed ID: 30530194 [TBL] [Abstract][Full Text] [Related]
46. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity. Cao TM; Durrant D; Tripathi A; Liu J; Tsai S; Kellogg GE; Simoni D; Lee RM Am J Hematol; 2008 May; 83(5):390-7. PubMed ID: 18175355 [TBL] [Abstract][Full Text] [Related]
47. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site. Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319 [TBL] [Abstract][Full Text] [Related]
48. Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective. Wang J; Miller DD; Li W Drug Discov Today; 2022 Mar; 27(3):759-776. PubMed ID: 34890803 [TBL] [Abstract][Full Text] [Related]
50. Design, Synthesis, and Biological Evaluation of Chalcone-Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization. Qiu HY; Wang F; Wang X; Sun WX; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH ChemMedChem; 2017 Mar; 12(5):399-406. PubMed ID: 28211616 [TBL] [Abstract][Full Text] [Related]
51. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site. Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102 [TBL] [Abstract][Full Text] [Related]
52. A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin. Xian J; Bu F; Wang Y; Long F; Zhang Z; Wu C; Tao Y; Wang T; Wang G Molecules; 2021 Feb; 26(4):. PubMed ID: 33579052 [TBL] [Abstract][Full Text] [Related]
53. Development of a novel class of tubulin inhibitors with promising anticancer activities. Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368 [TBL] [Abstract][Full Text] [Related]
55. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents. Qian Y; Zhang HJ; Lv PC; Zhu HL Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623 [TBL] [Abstract][Full Text] [Related]
56. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents. Habibpour E; Ahmadi S Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704 [TBL] [Abstract][Full Text] [Related]
57. Discovery of Novel Diarylamide Liu X; Pang XJ; Liu Y; Liu WB; Li YR; Yu GX; Zhang YB; Song J; Zhang SY Molecules; 2021 Jul; 26(13):. PubMed ID: 34279387 [TBL] [Abstract][Full Text] [Related]
58. Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities. Wang Q; Arnst KE; Wang Y; Kumar G; Ma D; Chen H; Wu Z; Yang J; White SW; Miller DD; Li W J Med Chem; 2018 Sep; 61(17):7877-7891. PubMed ID: 30122035 [TBL] [Abstract][Full Text] [Related]